Pre-eclampsia, diagnosis and treatment

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 11, 2001, Pages 1817-1824

  Sunanda, G V ^a   Johanson, R ^a  

^a UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

Author keywords

Diagnosis; Pathogenesis; Pre eclampsia; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIAZOXIDE; DIHYDRALAZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDRALAZINE; KETANSERIN; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; NIMODIPINE; NITROPRUSSIDE SODIUM; PHENYTOIN; PLACEBO; PROSTACYCLIN; UNINDEXED DRUG; URAPIDIL; VASODILATOR AGENT;

BABY; BLOOD PRESSURE; CONSERVATIVE TREATMENT; DELIVERY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MANAGEMENT; DOPPLER FLOWMETRY; DRUG MECHANISM; DRUG POTENTIATION; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNE RESPONSE; MALADJUSTMENT; MEDICAL RESEARCH; PATHOGENESIS; PREECLAMPSIA; PREGNANCY DISORDER; PROPHYLAXIS; PROTEINURIA; REPRODUCTION; REVIEW; RISK FACTOR; SEDATION; SLOW RELEASE FORMULATION; STANDARD; TACHYCARDIA; TREATMENT PLANNING; UTERINE ARTERY; VERTIGO;

ADULT; ANTICONVULSANTS; FEMALE; FLUID THERAPY; HUMANS; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY;

EID: 0035166368     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.11.1817     Document Type: Review

References (50)

1. International Collaborative study of hypertensive disorders of pregnancy: Geographic variation in the incidence of hypertension in pregnancy
2. Complications of pre-eclampsia
3. Etiology and pathogenesis of pre-eclampsia: Current concepts
4. Pre-eclampsia: An excess of inflammatory response to pregnancy
5. New insights into the genetics of pre-eclampsia
6. What is the place of genetics in the pathogenesis of pre-eclampsia?
7. Clinical management of established pre-eclampsia
8. Hypertensive disorders of pregnancy
9. Randomised trial of management of hypertensive pregnancies by Korotkoff Phase IV or Phase V
10. The importance of urinary protein excretion during conservative management of severe pre-eclampsia
11. Classification of hypertension in pregnancy
12. Improved methods of assessing proteinuria in hypertensive pregnancy
13. Hypertension in pregnancy
14. Pre-eclampsia
15. Assessment of changes in coagulation in parturients with pre-eclampsia using thromboelastography
16. Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin
17. Pre-eclamptic toxaemia: The role of uterine artery Doppler
18. Screening with a Uterine Doppler in low risk pregnant women followed by low dose aspirin in Women with abnormal results: A multicenter randomised controlled trial
19. Antiplatelet agents for preventing and treating pre-eclampsia (Cochrane Review)
20. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems (Cochrane Review)
21. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomised trial
22. Randomised controlled trial of day care for hypertension in pregnancy
23. Day care and pregnancy hypertension
24. Recent developments in the pathophysiology and management of pre-eclampsia
25. Oral beta-blockers for mild to moderate hypertension during pregnancy (Cochrane review)
26. Management of hypertension in pregnancy
27. Treatment of severe pre-eclampsia/eclampsia syndrome
28. A paradoxical haemodynamic effect of hydralazine
29. Magnesium and nifedipine: Potentiation of hypotensive effect in pre-eclampsia?
30. Severe pre-eclampsia and eclampsia
31. Drugs for rapid treatment of very high blood pressure during pregnancy (Cochrane review)
32. Treatment of hypertension in pregnancy with methyldopa: Blood pressure control and side effects
33. Final report of study on hypertension during pregnancy
34. Oral beta-blockers for mild to moderate hypertension during pregnancy (Cochrane review)
35. Atenolol in essential hypertension during pregnancy
36. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: A meta-analysis
37. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial
38. The management of pre-eclampsia
39. A comparison of magnesium sulphate with phentoin for the prevention of eclampsia
40. Use of anticonvulsants in eclampsia and pre-eclampsia: Survey of obstetricians in the UK and the Republic of Ireland
41. Anticonvulsants for women with pre-eclampsia (Cochrane review)
42. Magnesium sulphate for treatment of pre-eclampsia: A trial to evaluate the effects on women and their babies
43. Prevention of eclampsia
44. Plasma volume contraction: A significant factor in both pregnancy associated hypertension and chronic hypertension in pregnancy
45. Plasma volume expansion for treatment of women with pre-eclampsia
46. Haemodynamic observations in severe pre-eclampsia complicated by pulmonary edema
47. Expectant management of early onset, severe pre-eclampsia: Maternal outcome
48. Aggressive or expectant management for patients with severe pre-eclampsia between 28-34 weeks gestation. A randomised controlled trial
49. Aggressive versus expectant management of severe pre-eclampsia at 28-32 weeks gestation. A randomised controlled trial
50. Eclampsia in the United Kingdom